EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative network pharmacology, molecular dynamics simulation, and single-cell RNA sequencing strategies reveal the multi-target mechanisms of oridonin against cervical cancer

Min Xu, Tao Lu, Qing Lv, Kaiju Mo, Yanjie Liu

Frontiers in Pharmacology · 17.06.2026 · 17

DOI: 10.3389/fphar.2026.1788376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.06.2026. Verfasst von Min Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Guizhou Medical University, Guiyang, Guizhou, China. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cervical cancer remains a major threat to women’s health worldwide, and effective therapeutic strategies with clear molecular mechanisms are still needed. Oridonin (Ori), a natural diterpenoid compound, has shown antitumor activity in multiple malignancies; however, its regulatory mechanisms in cervical cancer, particularly at the single-cell level, remain incompletely understood.

Methods

In this study, an integrative strategy combining network pharmacology, bulk transcriptomic analyses, single-cell RNA sequencing (scRNA-seq), molecular docking, molecular dynamics simulations, and in vitro experiments was employed to systematically investigate the pharmacological effects and mechanisms of oridonin in cervical cancer. Differentially expressed genes were identified from multiple Gene Expression Omnibus datasets, and core targets were screened through protein–protein interaction analysis. Immune infiltration patterns were evaluated using CIBERSORT, while cell-type–specific pathway activities were inferred based on scRNA-seq data. The predicted mechanisms were further validated by molecular simulations and functional assays in cervical cancer cell lines.

Results

Network pharmacology and transcriptomic analyses identified 25 core EMT-related targets of oridonin, with enrichment primarily in the PI3K/AKT signaling pathway. Immune infiltration analysis revealed that oridonin-associated targets were closely correlated with macrophages and T-cell subsets. Single-cell analysis demonstrated that PI3K/AKT and EMT-related pathways were predominantly enriched in epithelial tumor cells, suggesting cell-type–specific regulatory effects. Molecular docking and dynamics simulations indicated favorable binding potential between oridonin and AKT1. In vitro experiments confirmed that oridonin significantly inhibited cervical cancer cell proliferation, migration, and invasion, induced apoptosis, and suppressed epithelial–mesenchymal transition progression via downregulation of the PI3K/AKT pathway.

Conclusion

This study provides a systematic and multi-level characterization of the antitumor mechanisms of oridonin in cervical cancer. By integrating network pharmacology with single-cell transcriptomic analysis, our findings highlight the cell-type–specific modulation of the PI3K/AKT–EMT axis by oridonin, offering mechanistic insights and establishing a theoretical pharmacological basis that warrants future in vivo preclinical evaluation.

Schlagwörter

Stichwörter der Autor:innen

cervical cancerepithelial–mesenchymal transitionnetwork pharmacologyoridoninsingle-cell RNA sequencing

Autor:innen und Institutionen

  • Department of Pathology, Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Pathology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Pathology, Sandu Shui Autonomous County People's Hospital, Sandu, Guizhou, China.
  • Department of Pathology, Liupanshui Municipal People's Hospital, Liupanshui, China.
  • Department of Pathology, Pathology Morphology and Molecular Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, China.

Zitieren

APA

Xu, M., Lu, T., Lv, Q., Mo, K., & Liu, Y. (2026). Integrative network pharmacology, molecular dynamics simulation, and single-cell RNA sequencing strategies reveal the multi-target mechanisms of oridonin against cervical cancer. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1788376

Vancouver

Xu M, Lu T, Lv Q, Mo K, Liu Y. Integrative network pharmacology, molecular dynamics simulation, and single-cell RNA sequencing strategies reveal the multi-target mechanisms of oridonin against cervical cancer. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1788376

BibTeX
@article{Xu2026,
  author = {Xu, Min and Lu, Tao and Lv, Qing and Mo, Kaiju and Liu, Yanjie},
  title = {Integrative network pharmacology, molecular dynamics simulation, and single-cell RNA sequencing strategies reveal the multi-target mechanisms of oridonin against cervical cancer},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1788376}
}
Kostenlos starten →